Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Learn effective ways to ensure consistent cash flow that will help you manage your finances and maintain liquidity.
22,723 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A UK-listed bitcoin treasury company uncovers a counterintuitive edge: buying back its own stock can yield about 24% ...
Could a bold thesis around Oklo Inc. unlock life-changing gains? This forward-looking guide breaks down why nuclear e...
Bitcoin’s spot market remains in a cautious lull even as futures and options activity picks up. Analysts say the shif...
Geopolitical tensions and stubborn inflation are rattling markets. Even higher-income americans turning cautious sign...
A surprise turn in inflation and consumer confidence tests the nerves of investors. This guide explains what happens ...
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...
A retirement decision with life-long consequences, the timing of Social Security claims can quietly alter tens of tho...
Green Brick Partners stands out in a tougher housing market thanks to a land-heavy model and strict debt discipline, ...
As AI fuels energy needs, NuScale’s small modular reactors offer a faster, scalable path to cleaner power. This guide...
Private AI leaders OpenAI and Anthropic see valuations near $1 trillion as investors chase growth. A cooling IPO wind...